# Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")

> **NCT00955162** · PHASE4 · COMPLETED · sponsor: **Indivior Inc.** · enrollment: 270 (actual)

## Conditions studied

- Opioid Dependency

## Interventions

- **DRUG:** Buprenorphine (Subutex)
- **DRUG:** Buprenorphine/naloxone (Suboxone)

## Key facts

- **NCT ID:** NCT00955162
- **Lead sponsor:** Indivior Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-05
- **Final completion:** 2011-05
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955162, "Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00955162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*